No description available.

No description available.

Background: Herpes Simplex Virus Type 2 (HSV 2) is one of the most common sexually transmitted infections (STIs) worldwide. HSV 2 infection is a risk factor for the acquisition and transmission of other STIs. Aim: The aim of this study is to determine prevalence and predictors of HSV 2 infection in Durban, South Africa by using available data that has not been previously analysed for the purpose of adding scientific evidence to the existing body of knowledge relating to HSV 2. Method: The study involves secondary analyses of data collected as a prospective study which enrolled women who participated in a clinical trial. A total of 3472 sexually active women were screened in the primary study from two clinics in Durban. All consenting participants were tested for HIV, HSV 2, Trichomonas vaginalis (TV), Neisseria gonorrhoea (NG) and Chlamydia trachomatis (CT) infection. Results: There were 2532 women who had HSV 2 giving a prevalence of 73%. Of these, 53% also tested positive for HIV infection. In univariate analysis, co-infection with HIV was strongly associated with HSV2 (Odds Ratio (OR): 7.4, 95% Confidence Interval (CI): 6.0, 9.1, p<0.001). There was also an association between other STIs, such as CT, NG and syphilis and HSV 2, although only NG was significantly associated with prevalent of HSV 2 (OR: 2.3, 95% CI: 1.3, 4.1, p=0.005). Women older than 25 years of age more likely to have HSV 2 (OR: 2.4, 95% CI: 2.0,2.8, p<0.001). A risk of being infected with HSV 2 increased with the number of reported lifetime sexual partners Those with two and three or more were 2,5 and 4.6 times more likely to have HSV2 respectively (OR: 2.5, 95% CI: 2.1,3.1, p<0.001 and OR: 4.6, 95% CI: 3.8, 5.6, p<0.001 respectively). Women who had less than high school education were also found to have higher risk for HSV 2. Conclusion: The secondary analysis showed a high prevalence of HSV 2 infection and a strong association of HSV 2 and HIV. A significant association of HSV 2 was noted in women having more than two sex partners and lower high school education. Therefore, it is recommended that screening for HSV 2 among high risk populations be incorporated into the STI screening and treatment packages. / Prevalence and risk factors associated with HSV 2 / Herpes Simplex Virus Type 2 / HSV 2 / Department of Health Studies / M. (Public health)

Background: Herpes Simplex Virus Type 2 (HSV 2) is one of the most common sexually transmitted infections (STIs) worldwide. HSV 2 infection is a risk factor for the acquisition and transmission of other STIs. Aim: The aim of this study is to determine prevalence and predictors of HSV 2 infection in Durban, South Africa by using available data that has not been previously analysed for the purpose of adding scientific evidence to the existing body of knowledge relating to HSV 2. Method: The study involves secondary analyses of data collected as a prospective study which enrolled women who participated in a clinical trial. A total of 3472 sexually active women were screened in the primary study from two clinics in Durban. All consenting participants were tested for HIV, HSV 2, Trichomonas vaginalis (TV), Neisseria gonorrhoea (NG) and Chlamydia trachomatis (CT) infection. Results: There were 2532 women who had HSV 2 giving a prevalence of 73%. Of these, 53% also tested positive for HIV infection. In univariate analysis, co-infection with HIV was strongly associated with HSV2 (Odds Ratio (OR): 7.4, 95% Confidence Interval (CI): 6.0, 9.1, p<0.001). There was also an association between other STIs, such as CT, NG and syphilis and HSV 2, although only NG was significantly associated with prevalent of HSV 2 (OR: 2.3, 95% CI: 1.3, 4.1, p=0.005). Women older than 25 years of age more likely to have HSV 2 (OR: 2.4, 95% CI: 2.0,2.8, p<0.001). A risk of being infected with HSV 2 increased with the number of reported lifetime sexual partners Those with two and three or more were 2,5 and 4.6 times more likely to have HSV2 respectively (OR: 2.5, 95% CI: 2.1,3.1, p<0.001 and OR: 4.6, 95% CI: 3.8, 5.6, p<0.001 respectively). Women who had less than high school education were also found to have higher risk for HSV 2. Conclusion: The secondary analysis showed a high prevalence of HSV 2 infection and a strong association of HSV 2 and HIV. A significant association of HSV 2 was noted in women having more than two sex partners and lower high school education. Therefore, it is recommended that screening for HSV 2 among high risk populations be incorporated into the STI screening and treatment packages. / Prevalence and risk factors associated with HSV 2 / Herpes Simplex Virus Type 2 / HSV 2 / Department of Health Studies / M. (Public health)

Le criblage par siRNA de 49 protéines de l'hôte qui sont incorporées dans les particules matures du virus herpès simplex de type 1 (VHS-1) a révélé l'importance d'au moins 15 d’entre elle pour infectivité du virus (Stegen, C et al. 2013). Parmi celle-ci figure la protéine humaine DDX3X, qui est une ARN hélicase ATP-dépendante. Cette protéine multifonctionnelle participe à différents stages de l'expression génique, tels que la transcription, la maturation et le transport d'ARNm ainsi que la traduction. DDX3X est impliquée dans la réplication de plusieurs virus tels que le Virus de l’immunodéficience humaine de type 1 (VIH-1), l'hépatite B (VHB), le virus de la vaccine (VACV) et le virus de l'hépatite C (VHC). Le rôle exact de DDX3X dans le cycle de réplication du VHS-1 est toutefois inconnu. Ce mémoire consiste en l’étude détaillée de l'interaction de DDX3X avec le virus. De manière surprenante, tant l’inhibition que la surexpression de DDX3X réduit de manière significative l'infectivité du VHS-1. Fait intéressant, lorsque nous avons restauré la déplétion de DDX3X par une construction résistante aux ARNi utilisés, le virus pouvait de nouveau infecter les cellules efficacement, indiquant que le virus est sensible aux quantités de cette protéine de son hôte. Nos résultats indiquent de plus que le virus modifie la localisation de DDX3X et cause son agrégation tôt dès les premiers temps de l'infection. Cependant, le virus ne modifie pas les niveaux cellulaires de DDX3X dans deux des trois lignées cellulaires examinées. Nous avons également pu établir que cette protéine n'a pas d'effet sur l'entrée du VHS-1, suggérant qu’elle agit à un stade ultérieure de l’infection. En examinant cette relation plus en détail, nos résultats ont démontré que l’inhibition ou la surexpression de DDX3X inhibent toutes deux la production de nouvelles particules virales en réduisant l'expression des diverses classes cinétiques des protéines virales et ce au niveau de leur transcription. Malgré le rôle connu DDX3X dans la stimulation de la réponse immunitaire innée et la production d’interférons de type I, l’impact de DDX3X sur la réplication du VHS-1 est ici indépendante de cette fonction. Ces travaux démontrent donc une nouvelle voie d’action de DDX3X sur les virus en agissant directement sur la transcription de gènes viraux et la réplication du génome d’un virus à ADN. En comprenant mieux cette interactions hôtepathogène, il est maintenant envisageable de concevoir des nouvelles approches thérapeutiques contre ce virus. / siRNA screening of 49 host proteins that are known to be incorporated in the mature virions of herpes simplex virus type 1 (HSV-1) revealed the importance of at least 15 cellular proteins for viral infectivity (Stegen, C et al. 2013). Among these, was the human protein DDX3X, a DEAD-box ATP-dependent RNA helicase. This multifunctional protein participates in different stages of gene expression such as mRNA transcription, maturation, mRNA export and translation. DDX3X has been shown to be involved in the replication of several viruses such as human immunodeficiency virus type 1 (HIV-1), hepatitis B virus (HBV) vaccinia virus (VACV) and hepatitis C virus (HCV). The exact role of DDX3X in HSV-1 replication cycle is not known. Here we sought to find the detailed interaction between DDX3X with HSV-1. Surprisingly, the down-regulation as well as overexpression of DDX3X, significantly reduced the infectivity of HSV-1, indicating that the virus is sensitive to the precise levels of DDX3X. Accordingly, when we rescued DDX3X back to its normal cellular levels by sequential transfection of DDX3X siRNA and siRNA resistant DDX3X plasmid, the virus was able to infect cells efficiently compare to wild-type conditions. Furthermore, the virus changes the localization of DDX3X and causes its aggregation at early times in the infection. However, the virus does not change the cellular levels of DDX3X in at least two of three different cell lines tested. Using a luciferase assay we were able to establish that this protein has no effect on the entry of HSV-1. In fact, depleting or overexpressing DDX3X impaired the production on newly assembled viral particles by blocking the expression of all classes of viral proteins at the transcription level. Despite the known role of DDX3X in the stimulation of innate immune response and interferon type I production, DDX3X appears to act on HSV-1 replication independently of this pathway. This highlights a novel route of action of DDX3X by acting at the transcription level and the consequent genome replication of a DNA virus. By better understanding such pathogen interactions, it might now be possible to design novel therapeutic approaches.

Le virus de l’Herpès simplex de type 1 (HSV-1) est le pathogène humain responsable des lésions herpétiques labiales, plus communément appelé « feux sauvages ». Annuellement, il est responsable de plusieurs cas d’encéphalites et d’infections de l’appareil visuel qui sont la principale cause de cécité en Amérique du Nord. Bien qu’il existe quelques traitements antiviraux, aucun vaccin ou médicament ne permet de prévenir ou de guérir les infections causées par ce virus. Aujourd’hui, les infections produites par l’HSV-1 sont présentes partout sur la planète. Récemment, une étude en protéomique effectuée sur les virus matures extracellulaires a permis d’identifier la présence d’ubiquitines libres et d’enzymes reliées à la machinerie d’ubiquitination dans le virus. De plus, le virus exploite cette machinerie au cours de l’infection. Il est connu que certaines protéines virales sont ubiquitinées durant une infection et que le virus imite même certaines enzymes d’ubiquitination. Nous avons donc entrepris des recherches afin d’identifier des protéines virales ubiquitinées qui pourraient être présentes dans les virus matures ainsi que leurs rôles potentiels. La protéine majeure de la capside, VP5, un constituant très important du virus, a été identifiée. Nos recherches nous ont permis de caractériser le type d’ubiquitination, une monoubiquitination sur les lysines K810 et/ou K1275 de VP5. Le rôle que pourrait jouer l’ubiquitination de VP5 dans le cycle de réplication virale et dans les virus matures n’est toutefois pas encore connu. / Herpes simplex virus type 1 (HSV-1) is the human pathogen responsible for herpetic lesion such as cold sores. On a yearly basis, it is responsible for many cases of encephalitis and infections of the eye that are the most common cause of blindness in North America. Antiviral treatments exist, but no vaccines or drugs are able to prevent or cure the diseases caused by this virus. Today, infections caused by HSV-1 are present all around the world. Recently a proteomics approach was used to study mature extracellular viruses. This study highlighted the presence in the virus of free ubiquitin and ubiquitin related enzymes. Furthermore, the virus exploits this machinery during the course of infection. Also, it is known that certain virally encoded proteins are ubiquitinated and that the virus mimics some ubiquitin related enzymes. Our researches focused on identifying ubiquitinated viral proteins that could be present in mature extracellular viruses and their potential roles. The major capsid protein, VP5, an important virus component, was identified. We characterised the type of ubiquitination, a monoubiquitination of lysine K810 and/or K1275 of VP5. The role that could play the ubiquitination of VP5 in the viral cell cycle and in mature virions has yet to be identified.

Les virus exploitent la machinerie cellulaire de l’hôte de façon très variée et plusieurs types vont même jusqu’à incorporer certaines protéines cellulaires. Nous avons récemment effectué la première analyse protéomique du virion mature de l’Herpès simplex de type 1 (HSV-1), ce qui nous a permis de déterminer que jusqu’à 49 protéines cellulaires différentes se retrouvaient dans ce virus (Loret, S. et al. (2008). "Comprehensive characterization of extracellular herpes simplex virus type 1 virions." J Virol 82(17): 8605-18.). Afin de déterminer leur importance dans le cycle de réplication d’HSV-1, nous avons mis au point un système de criblage nous permettant de quantifier le virus produit et relâché dans le milieu extracellulaire en utilisant un virus marqué à la GFP ainsi que des petits ARN interférents (pARNi) ciblant spécifiquement ces protéines cellulaires. Cette approche nous a permis de démontrer que 17 des protéines identifiées précédemment jouaient un rôle critique dans la réplication d’HSV-1, suggérant ainsi que leur incorporation dans le virus n’est pas aléatoire. Nous avons ensuite examiné le rôle d’une de ces protéines, DDX3X (DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked), une protéine multifonctionnelle connue pour son implication dans les cycles de réplication de plusieurs virus humains. À l’aide de pARNi ainsi que de différentes lignées cellulaires, dont une lignée DDX3X thermosensible, nous avons démontré que l’inhibition de DDX3X résultait en une diminution du nombre de capsides intracellulaires et induisait une importante diminution de l’expression des gènes viraux. Nous avons aussi démontré que la fraction de DDX3X incorporée dans le virion contribuait activement au cycle infectieux d’HSV-1. Ces résultats confirment l’intérêt de notre approche afin d’étudier les interactions hôte-pathogène en plus de démontrer la contribution des protéines cellulaires incorporées à HSV-1 dans l’infection virale. / Viruses exploit the cellular machineries in many ways and several viruses specifically incorporate host proteins. To understand their biological relevance, we recently performed the first comprehensive characterization of the mature herpes simplex virus type 1 (HSV-1) in which up to 49 distinct cellular proteins were identified by mass spectrometry. In the present study, we sought to identify which of these cellular factors are critical for the HSV-1 life cycle. To this end, we performed a functional screen using small interfering RNA (siRNA) and a GFP-tagged virus, which indicated that at least 17 of the virion-incorporated host proteins alter HSV-1 proliferation in cell culture. Interestingly, these include several Rab GTPases and other intracellular transport components as well as proteins involved in signal transduction, gene regulation and immunity. Among them, the DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked protein (DDX3X) is a multifunctional molecule previously linked to several other viruses. Its relevance for HSV-1 was further confirmed with different siRNA reagents and cell lines, including a DDX3X thermosensitive cell line. We found that DDX3X inactivation reduced intracellular capsid abundance via a strong inhibition of viral gene expression. We also report evidence that the pool of DDX3X present in the mature virions actively contributes to HSV-1 life cycle. Altogether, this highlights a powerful and biologically relevant approach to characterize host-pathogen interactions and points to the important contribution host proteins within mature viral particles.

Zhu Wen. / "May 2002." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2002. / Includes bibliographical references (p. 217-249). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. Ann Arbor, MI : ProQuest Information and Learning Company, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.

Introducción: Diversos estudios transversales han demostrado el impacto negativo quela violencia de pareja tiene en la salud mental, en la salud física y en el funcionamientode los sistemas fisiológicos de las mujeres. Si bien, han sido pocos los estudioslongitudinales realizados para establecer la evolución de dicho impacto en la salud delas mujeres a lo largo del tiempo. Objetivos: En este estudio se pretendió, en primerlugar, determinar la evolución del estado de salud física y del funcionamiento delsistema inmune de las mujeres víctimas de violencia de pareja y, en segundo lugar,establecer los factores personales y sociales que contribuyen a la recuperación de lasalud o la perjudican. Métodos: Las mujeres (n=91) que participaron en un estudiotransversal previo (T-1) fueron evaluadas tres años después (T-2): mujeres víctimas deviolencia psicológica (n=23), mujeres víctimas de violencia física/psicológica (n=33) ymujeres control en cuya relación de pareja no existía violencia (n=35). Tanto en elestudio transversal (T-1) como en el estudio longitudinal (T-2) se llevaron a caboentrevistas estructuradas a través de las cuales se recogió información sobrecaracterísticas sociodemográficas, relaciones de pareja, características de la violencia depareja, historial de victimización, salud física, apoyo social y acontecimientos vitales. Elestado de salud física de las mujeres se midió a través de tres indicadores: incidencia desíntomas físicos, incidencia de enfermedades físicas y utilización de servicios de salud.Finalmente, en ambos momentos temporales se recogieron muestras de saliva paraevaluar el control del sistema inmune sobre el virus Herpes simple tipo 1 (HS-1) através de tres medidas: neutralización del virus HS-1, cantidad de inmunoglobulina A(IgA) específica contra el virus HS-1 (IgA HS-1) y cantidad total de IgA en la saliva(IgA total). Resultados: La incidencia de síntomas físicos disminuyó significativamentea lo largo del tiempo en ambos grupos de mujeres víctimas de violencia de pareja,psicológica y física/psicológica, si bien se observó una mayor disminución en lasmujeres víctimas de violencia física/psicológica. Los factores que contribuyeron a estarecuperación fueron el estado de salud física de las mujeres en T-1, el grado de apoyosocial percibido y el cese de la violencia física. Por el contrario, los factoresperjudiciales para su recuperación fueron el consumo de psicofármacos, la convivenciacon el agresor, las experiencias de victimización en la edad adulta durante T-2, lapercepción negativa de los acontecimientos vitales y el mantenimiento de la violenciapsicológica. Por otro lado, en las mujeres víctimas de violencia física/psicológica seprodujo una disminución a lo largo del tiempo en la cantidad total de enfermedadesagudas padecidas, así como en el número de veces que utilizaron los servicios deurgencia por motivos de violencia. En cuanto al funcionamiento del sistema inmune a lolargo del tiempo, las mujeres víctimas de violencia física/psicológica mostraron unaumento tanto en la capacidad para neutralizar el virus HS-1 como en los niveles de IgAHS-1. El cese de la violencia física fue el principal factor predictor de dicharecuperación. Conclusiones: Este estudio muestra que es posible la recuperación de lasalud física previamente deteriorada en mujeres que han sido víctimas de violencia depareja, psicológica o física/psicológica. Además, indica que es posible la recuperacióndel control inmune sobre el virus HS-1 en mujeres que han estado expuestas a violenciafísica/psicológica a pesar de su baja capacidad antiviral inicial. Son necesarios otrosestudios longitudinales para determinar los factores que mejor predicen la recuperaciónde la salud de las mujeres con la finalidad de diseñar programas de intervención máseficaces. / Introduction: Several cross-sectional studies have demonstrated the negative impactthat intimate partner violence (IPV) has on women's health. However, few longitudinalstudies have been carried out to establish the course of this impact over time.Objectives: This study pretended to determine the course of the physical health and theimmune system function on women victims of IPV and to establish the factors thatcontribute or impair to its recovery. Methods: Women (n=91) who took part in aprevious cross-sectional study (T-1) were evaluated three years later (T-2): victims ofpsychological IPV (n=23), victims of physical/psychological IPV (n=33) and controlwomen (n=35). Information about characteristics of IPV, physical health and lifestylevariables was obtained by structured interviews. Finally, saliva samples were collectedto assess the immune system control over Herpes simplex virus type 1 (HSV-1).Results: The incidence of physical symptoms decreased in time in both groups ofwomen, psychological and physical/psychological victims of IPV. Factors thatcontributed to this recovery were the women's health condition in T-1, the socialsupport and the physical IPV cessation. On the contrary, factors that impaired thisrecovery were the psychopharmacological treatment, the cohabitation with theaggressor, the experiences of victimization during T-2, the negative perception of lifeevents and the continuation of psychological IPV. Furthermore, the amount of acutediseases suffered by women and the visits to emergency rooms because of violencereasons decreased in time in physical/psychological IPV victims. With regard to thecourse of immune system over time, women who were victims ofphysical/psychological IPV had a significant improvement in both the capacity toneutralize HSV-1 and HSV-sIgA levels. Physical IPV cessation was the main predictorof this recovery. Conclusions: This study shows that physical health recovery ispossible in women that have been IPV victims. Furthermore, it shows that recovery ofimmune control over HSV-1 is possible in women who have been exposed tophysical/psychological IPV. Other longitudinal studies are needed to determine whichfactors best predict the restoration of health in order to design effective interventionprograms.

Background: The Division of Global HIV/AIDS at the Centers for Disease Control and Prevention (CDC) is working on a public health evaluation (PHE) in the eastern districts of Botswana. This PHE aims to evaluate the effectiveness of Project AIM, a group-level intervention designed to reduce HIV risk behaviors in youth ages 11 to 14, when combined with the regular Botswana Skills for Life Curriculum, a standard HIV prevention education curriculum in Botswana schools. In order to evaluate Project AIM, a self-report survey and a biological testing for herpes simplex virus type 2 (HSV-2) will be conducted. Methodology: Based on studies done on the psychosocial impact of HSV-2 diagnosis on asymptomatic individuals in the USA, the literature recommends providing pre and post counseling and education to individuals testing for genital herpes to help cope and diminish the psychosocial impact of the diagnosis. In order to prepare Botswana’s clinics and schools participating in the PHE to provide the support for newly diagnosed adolescents with HSV-2, guidance materials were developed for health care practitioners and school guidance teachers. Materials were created using Information Mapping technique to analyze, organize, and present the information, and the Microsoft Office Flesch Kinkade Grade Level (FK) tool to assess the readability levels of the materials. Results: Guidance materials were prepared using the 7±2 theoretical limit of human short-term memory information mapping rule, and the FK grade levels of 6.0 to 8.0 recommended readability scores. Guidance materials included information regarding HSV-2 symptoms, treatment, and prevention. They also included information on the PHE study, youth friendly health services, counseling and education, clinic referrals and contact information. Conclusions: The development of guidance materials for schools and clinic participants of the CDC PHE in Botswana will provide health practitioners and school guidance teachers with accurate HSV-2 information to counsel and educate student participants in this research study. The guidance materials should help students cope with potential psychosocial disorders associated with pre and post diagnosis of HSV-2.